Yaz and Yasmin (Drospirenone/ethinyl estradiol)

The prescription birth control pills Yaz (Drospirenone 3 mg and ethinyl estradiol 0.02 mg)and Yasmin (Drospirenone 3 mg and ethinyl estradiol 0.03 mg) have been prescribed to hundreds of thousands of women to prevent pregnancy. These drugs have been linked to several serious medical conditions, including, but not limited to heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism, blood clots, abnormal heart rhythm, gallbladder injury, and pancreatitis. In April of 2012, the United States Food and Drug Administration issued the following warning regarding these medications: “Based on presently available information on Yasmin, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins.” On April 10, 2012, the United States Food and Drug Administration issued the following Safety Communication regarding these medications: “The U.S. Food and Drug Administration (FDA) has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin.  Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.  See Table 1 for a list of drospirenone-containing products.” This Safety Communication further stated, “The revised drug labels (Beyaz, Safyral, Yasmin and Yaz) will report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products.”

Bayer, the manufacturer of Yaz has issued the following warnings on the Yaz website: “Users of drospirenone-containing pills (like Beyaz and YAZ) may have a higher risk of blood clots than users of birth control pills that do not contain drospirenone.” Bayer, the manufacturer of Yasmin has issued the following warnings on the Yasmin website: “Users of drospirenone-containing pills (like SAFYRAL and YASMIN) may have a higher risk of blood clots than users of birth control pills that do not contain drospirenone.”

If your physician has prescribed Yaz or Yasmin for you, you should immediately discuss whether there are safer alternative drugs for you. After weighing the risks and benefits, you and your physician can determine what drug is best for you. If you live in California, have taken Yaz or Yasmin, and have suffered heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism, blood clots, abnormal heart rhythm, gallbladder injury, or pancreatitis, you should know that attorney and physician Paul J. Molinaro is available to answer your legal questions and help you determine whether you are entitled to compensation from the manufacturer of this drug. You can reach Paul J. Molinaro, M.D. J.D. toll free at (888)MDJDLAW. The initial consultation is also free, and if Paul determines that you have a case, and you decide to hire Paul, he will represent you on a contingent basis.

Ratings and Reviews